Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesIntravenous Tissue Plasminogen Activator for Stroke: A Review of the ECASS III Results in Relation to Prior Clinical Trials
The Journal of Emergency Medicine, 09/21/09
Cronin CA – The benefits of thrombolysis with IV tPA for acute ischemic stroke outweigh the risks of treatment for selected patients up to 4.5 h from symptom onset. It is already known that thrombolysis is not beneficial for all stroke patients and strict criteria should be applied before treatment. As time from symptom onset increases, the need for careful patient selection likely also increases.
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
How triggers trigger acute migraine attacks: A hypothesis
Medical Hypotheses, 11/23/09
Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of beta2-adrenoceptor
Nephrology Dialysis Transplantation, 11/05/09
Today in Neurology/Neurosurgery...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Stroke treatment with alteplase given 3·0—4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
The Lancet Neurology, 11/17/09
Safety and Efficacy of IV-TPA for Ischaemic Stroke in Clinical Practice - A Bayesian Analysis
Cerebrovascular Diseases, 10/30/09
Article Search
Sponsor